CHICAGO, Aug. 06, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company […]
Commercialization and launch of first royalty bearing products position company for next phase of growthMultiple U.S. health plans add Teriparatide […]